medRxiv PreprintsInternational5 October 2026
Release-aware, SAS-equivalent Elixhauser comorbidity scoring in R: cross-implementation validation and application to Texas inpatient discharges
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
The Elixhauser comorbidity measures are among the most widely used risk adjusters in administrative health data. Their reference implementation, published by the Agency for Healthcare Research and Quality (AHRQ) as SAS programs, has eleven annual releases in two families, one screening pre-existing conditions on the present-on-admission (POA) indicator and the earlier one on Medicare Severity Diagnosis-Related Group, and no implementation of every release existed outside SAS. We developed `ecsr10`, an open-source R package covering all eleven releases of both families, with a browser-based app
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Acquisition Speed versus Spatial Resolution in Ultra-High-Resolution Photon-Counting CT: Phantom Study to Guide Protocol Development6 October 2026
- Predicting Cervical Cancer Screening Utilization Among Women of Reproductive Age in Ethiopia Using Supervised Machine Learning: A Nationally Representative 2024/25 EDHS Study6 October 2026
- Overdose-related communication in Connecticut: reported receipt, perceived utility, and responses among overdose prevention and response professionals6 October 2026
- Diabetes Polygenic Scores Predict Glycemic Indices and Insulin Use in Individuals with Atypical Diabetes6 October 2026
- Right Versus Left Ventricular Myofiber Orientation in Various Congenital Heart Diseases Analyzed with X-Ray Phase-Contrast Tomography6 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.